SIM
IMNP

Spark Investment Management’s Immune Pharmaceuticals Inc. IMNP Stock Holding History

Spark Investment Management’s Portfolio IMNP Stock Details IMNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-675
Closed -$25K – 807
2014
Q4 		$25K Buy
675
+100
+17% +$5.38K ﹤0.01% 664
2014
Q3 		$36K Buy
+575
New +$40.9K 0.01% 648

Other funds holding IMNP

PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
EEG
E.E. Geduld $178M AUM 29.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
IFS
Ifrah Financial Services Little Rock, Arkansas $409M AUM 28.15% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Spark Investment Management's IMNP Position: Q1 2015 in Review

Spark Investment Management sold out of Immune Pharmaceuticals Inc. (IMNP) in Q1 2015, closing a stake of 675 shares — an estimated $25K sold.

Spark Investment Management first reported a position in IMNP in Q3 2014 and held it in 2 quarters. The position peaked at $36K in Q3 2014. 12 funds tracked by Wall St. Rank hold IMNP as of Q1 2015.

  • Spark Investment Management reported no remaining Immune Pharmaceuticals Inc. position as of Q1 2015 after selling out during the quarter.
  • Spark Investment Management sold 675 Immune Pharmaceuticals Inc. shares in Q1 2015, an estimated $25K.
  • Spark Investment Management first reported a position in Immune Pharmaceuticals Inc. in Q3 2014 and held it in 2 quarters.
  • Spark Investment Management's Immune Pharmaceuticals Inc. position peaked at $36K in Q3 2014.
  • 12 funds tracked by Wall St. Rank held Immune Pharmaceuticals Inc. as of Q1 2015.

Based on Spark Investment Management's 13F filing for Q1 2015, filed 12 May 2015.